Please login to the form below
PMLive
This page shows the latest PMLive news and features for those working in and with pharma, biotech and healthcare.
BMS’ new JAK inhibitor enters regulatory pathways
In spite of ongoing safety concerns for the class as a whole, BMS’s selective JAK inhibitor deucravacitinib has been accepted for review by regulatory agencies
Latest news
-
COVID-19 vaccines against Omicron may be fast-tracked
Regulators including the Food and Drug Administration (FDA) may treat Omicron-specific mRNA vaccines like seasonal flu vaccines, speeding up approval
-
Omicron prompts global action
A new variant of concern discovered in southern Africa is quickly spreading around the world, prompting government to take action
-
Novo Nordisk growth takes a hit with China deal
Danish diabetes specialist Novo Nordisk cuts its growth forecast for 2022 following a value-based procurement deal with the Chinese government for its insulin products
-
New COVID variant causing concern
An ‘unusual constellation of mutations’ in a new variant of the virus that causes COVID-19 has scientists worried that it could impact the efficacy of vaccines
-
First trial of a vaccine against Alzheimer’s launches
Researchers in the US hope that the vaccine can stimulate the brain’s immune system to clear the amyloid plaques seen in Alzheimer’s
More from news
Approximately 1 fully matching, plus 7,583 partially matching documents found.
Latest Intelligence
-
Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
By Michael Brandreth, Group Vice President of Medscape
-
Healthcare creatives need to be more like Bryson
By James Mayfield
-
How should healthcare harness creativity?
By Rob Gale. Before we explore answering this question there are a couple of other questions I need to answer first. Firstly, and most difficultly, how do we define creativity? The answer to this can differ wildly from person to person but it is
-
Curb your conservatism: can pharma ditch its cautious approach to creativity in comms?
Chris Ross explores innovation in healthcare comms and finds creativity shouldn’t be comfortable
-
Mitigating misinformation: the importance of effective communication during a public health crisis
By Julie Beeso
More from intelligence
Approximately 0 fully matching, plus 1,484 partially matching documents found.
Latest appointments
-
Blue Latitude grows senior team
Healthcare consultancy expands in its core capabilities with new hires
-
Merck KGaA appoints Isabel De Paoli as communications head
She will replace Walter Huber, who retires inMarch 2016
-
MedImmune appoints Dr Christopher Rhodes
Will head cardiovascular and metabolic diseaseresearch for the AZ unit
-
Spink appoints ex political comms head
James Butcher to lead awareness campaigns for the healthcare comms agency
-
Merck & Co expands board and adds new directors
Appoints Dr Paul Rothman and Pamela Craig
More from appointments
Approximately 0 fully matching, plus 1,000 partially matching documents found.
Latest from PMHub
-
Onyx Health Announces Two Top Appointments
Onyx health have made two senior appointments to their communications team. Healthcare marketing communication specialists Onyx Health have made two new senior appointments, following a year of record income growth and international client expansion.
-
As HCPs Increasingly Expect Personalized Engagement, Pharmas Turn to Modular Intelligent Content. How Does This Work?
While personalized omnichannel communication is becoming the only truly acceptable option in brand communications, Life Sciences are deeply affected by the change. Compared to retail, the amounts of information to deliver alongside the key message
-
Lucid Group: Orange the World
Yesterday was International Day For The Elimination Of Violence Against Women. It marked the launch of the UNiTE to end the violence against women campaign, which runs for 16 days until the 10 December. The Lucid Group D&I committee has been busy
-
Webinar:
Securing a future for telehealth with immersive market research insights. Register now for the fourth webinar in our digital series, in which Director, An-hwa Lee and Associate Director, Marietta Fernandes will investigate the current landscape,
-
Impetus Digital wins Canada’s Most Admired Corporate Cultures Awards 2021
Toronto, ON, November 25, 2021– After a lengthy submission and voting process and amongst fierce competition, Impetus Digital has been selected as a winner of Canada’s Most Admired Corporate Cultures Awards 2021 in the Emerging Company category
More from PMHub
Approximately 1 fully matching, plus 1,001 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
-
B2B media account director
-
Competitive salary
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- First trial of a vaccine against Alzheimer’s launches
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- bluebird bio’s beti-cel accepted for priority review by FDA
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- As HCPs Increasingly Expect Personalized Engagement, Pharmas Turn to Modular Intelligent Content. How Does This Work?
- COVID-19 vaccines against Omicron may be fast-tracked
- BMS’ new JAK inhibitor enters regulatory pathways
- Onyx Health Announces Two Top Appointments
- Omicron prompts global action
- Novo Nordisk growth takes a hit with China deal
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Six ways to improve diversity in clinical trials
- Innovation in a digital context is not about technology – it’s about people
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Novartis forms coronavirus alliance with life sciences companies
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
- Six ways to improve diversity in clinical trials
- Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...
